| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2021 Q4 | - | Riverwater Sustainable Value Strategy | - | - | AEM, ATKR, BLDR, CIEN, CMBM, CRL, CTT, EEFT, HASI, INFU, JLL, LEVI, RDHL, REGI, THRM, VRS, ZBRA | Electric Vehicles, Esg, Quality, SMID Cap, sustainability, value | THRM LEVI RDHL VRS ATKR |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Fund Letters | Riverwater Sustainable Value Strategy | Redhill Biopharma | Drug Manufacturers - Specialty & Generic | Biotechnology | Bear | NASDAQ | biotechnology, capital allocation, COVID Treatment, Dilution, Failed Trial, GI Therapeutics | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||